330 related articles for article (PubMed ID: 21784892)
21. Improvement of idiopathic membranous nephropathy diagnosis with ultrasensitive quantitative detection of anti-phospholipase A2 receptor.
Huang B; Wang L; Cao YN; Zhang Y; Zhang J; Xiao H; Zhang Q; Wang W; Sun Z; Chen Y; Hu Z; Sheng H
J Allergy Clin Immunol; 2017 Jun; 139(6):1988-1990.e2. PubMed ID: 27876629
[No Abstract] [Full Text] [Related]
22. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
23. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
Hill PA; McRae JL; Dwyer KM
Nephrology (Carlton); 2016 May; 21(5):397-403. PubMed ID: 26369693
[TBL] [Abstract][Full Text] [Related]
24. Recent advances and prognosis in idiopathic membranous nephropathy.
Segal PE; Choi MJ
Adv Chronic Kidney Dis; 2012 Mar; 19(2):114-9. PubMed ID: 22449349
[TBL] [Abstract][Full Text] [Related]
25. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy.
Obrisca B; Ismail G; Jurubita R; Baston C; Andronesi A; Mircescu G
Biomed Res Int; 2015; 2015():249740. PubMed ID: 26576418
[TBL] [Abstract][Full Text] [Related]
27. The pathogenesis of membranous nephropathy: evolution and revolution.
Glassock RJ
Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
[TBL] [Abstract][Full Text] [Related]
28. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
[TBL] [Abstract][Full Text] [Related]
29. The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis.
Rao SJ; Shen Q; Wang HM; Tang S; Wang XY
Int Urol Nephrol; 2020 Nov; 52(11):2123-2133. PubMed ID: 32767251
[TBL] [Abstract][Full Text] [Related]
30. Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up.
van de Logt AE; Hofstra JM; Wetzels JF
Kidney Int; 2015 Jun; 87(6):1263-4. PubMed ID: 26024039
[No Abstract] [Full Text] [Related]
31. [Diagnostic value of IgG subtypes in membranous nephropathy: A case report].
Asmandar S; Figuères ML; Goujon JM; Noël LH; Hummel A
Nephrol Ther; 2015 Jun; 11(3):169-72. PubMed ID: 25921735
[TBL] [Abstract][Full Text] [Related]
32. Human idiopathic membranous nephropathy--a mystery solved?
Glassock RJ
N Engl J Med; 2009 Jul; 361(1):81-3. PubMed ID: 19571287
[No Abstract] [Full Text] [Related]
33. Serum anti-PLA2R antibodies may be present before clinical manifestations of membranous nephropathy.
Guerry MJ; Vanhille P; Ronco P; Debiec H
Kidney Int; 2016 Jun; 89(6):1399. PubMed ID: 27181779
[No Abstract] [Full Text] [Related]
34. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
35. Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy.
Huang X; Qin W; Zhang M; Zheng C; Zeng C; Liu Z
Am J Med Sci; 2013 Jul; 346(1):32-7. PubMed ID: 23103439
[TBL] [Abstract][Full Text] [Related]
36. Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.
Thokhonelidze I; Maglakelidze N; Sarishvili N; Kasradze T; Dalakishvili K
Georgian Med News; 2015 Apr; (241):49-53. PubMed ID: 25953939
[TBL] [Abstract][Full Text] [Related]
37. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
[TBL] [Abstract][Full Text] [Related]
38. Can we manage without biopsy in membranous nephropathy with positive anti-PLA2R antibodies?
Ruiz Martínez L; Fernández Fresnedo G; Rodrigo E; Heras M
Nefrologia (Engl Ed); 2019; 39(3):311-312. PubMed ID: 30243493
[No Abstract] [Full Text] [Related]
39. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods.
Katsumata Y; Okamoto Y; Moriyama T; Moriyama R; Kawamoto M; Hanaoka M; Uchida K; Nitta K; Harigai M
Immunol Med; 2020 Mar; 43(1):47-56. PubMed ID: 31910103
[TBL] [Abstract][Full Text] [Related]
40. Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.
Brenchley PE
J Am Soc Nephrol; 2015 Oct; 26(10):2308-11. PubMed ID: 25804283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
